Related Experiment Videos

Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis

Shu-ichi Okamoto1, Zhen Li, Chung Ju

  • 1Center for Neuroscience and Aging, Apoptosis and Cell Death Research Program, The Burnham Institute, La Jolla, CA 92037, USA.

Insights

Excitotoxic stress cleaves Myocyte enhancer factor-2 (MEF2) transcription factors in mature neurons, leading to apoptosis. Restoring MEF2 activity prevents this neuronal death, suggesting a key role in stroke damage.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Death Research

Background:

  • Myocyte enhancer factor-2 (MEF2) transcription factors regulate neuronal differentiation and survival.
  • MEF2 activation by p38 MAPK is crucial for development but can be proapoptotic in stressed mature neurons.

Purpose of the Study:

  • To investigate the role of MEF2 in excitotoxic neuronal apoptosis.
  • To elucidate the mechanism of MEF2 cleavage and its functional consequences in neuronal stress.

Main Methods:

  • Utilized N-methyl-D-aspartate (NMDA) insults on mature cerebrocortical neurons.
  • Assessed caspase activation and MEF2 cleavage.
  • Employed transfection of constitutively active MEF2 (MEF2C-CA) and dominant-interfering MEF2 constructs.
  • Examined MEF2 cleavage fragments in vivo during focal stroke models.

Main Results:

  • NMDA insults activated caspases-3 and -7, leading to cleavage of MEF2A, C, and D isoforms.
  • MEF2 cleavage fragments inhibited MEF2 transcriptional activity via dominant interference.
  • Constitutively active MEF2 (MEF2C-CA) rescued MEF2 activity and prevented NMDA-induced apoptosis.
  • Dominant-interfering MEF2 blocked the neuroprotective effects of MEF2C-CA.
  • Similar MEF2 cleavage fragments were observed in vivo during focal stroke damage.

Conclusions:

  • A novel pathway involving caspase-catalyzed MEF2 cleavage mediates excitotoxic neuronal apoptosis.
  • This pathway has significant pathophysiological relevance in vivo, particularly in conditions like stroke.
  • Targeting MEF2 cleavage may offer therapeutic strategies for neuroprotection.

Related Concept Videos